Table 2.
Results | |
---|---|
n=22 | |
Time from symptoms to embolization (weeks) (mean, range, SD) | 59.6 (6-216, 48.6) |
VAPS before embolization (mean, range, SD) | 8.4 (4-10, 1.6) |
VAPS after embolization (mean, range, SD) | 5.2 (0-10, 3.2) |
Time from embolization to VAPS (months) (mean, range, SD) | 10.2 (3-24, 7.9) |
Symptom improvement after embolization (n, %) | 17 (77.3) |
Minor complications (n, %) | 4 (18.2) |
n=21 | |
Diameters of periuterine veins (mm) on MR before embolization (mean, range, SD) | 6.7 (3-10, 1.6) |
n=13 | |
Diameters of periuterine veins (mm) on MR after embolization (mean, range, SD) | 4.9 (2-7, 1.5) |
n=12 | |
Reduction of periuterine vein diameter after embolization (n, %) | 8 (66.7) |
Legend: (VAPS) Visual analog pain scale; (SD) Standard deviation; (MR) Magnetic resonance; (N) Patient number.